Spectrum bladder cancer drug not effective - U.S. FDA panel

Sept 14 (Reuters) - Spectrum Pharmaceuticals Inc's

experimental bladder cancer treatment apaziquone is not

effective in delaying the time to recurrence of the disease, an

advisory committee to the...

Read more